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Abstract 
Background 
Acute respiratory tract infection is common illness of human with significant morbidity and 
mortality. In pediatrics, viruses are the major cause if this illness. There is an imperative need to 
develop a diagnostic tool to measure viral diversity for preventing contraproductive treatments. 
This present study focuses on evaluating viruses from clinical samples of respiratory tract 
infection by using advanced diagnostic method such as microarray technology.  
Methods 
Target was amplified using random amplification. Indirect method of hybridization was used to 
fluorescently label target with Cy3. A previously developed LLMDA subarray 2 (GPL13407) 
was demonstrated as detectichip. This chip comprise of 58,000 probes. The detectichip was 
designed by Agilent technologies. Samples were hybridized on this chip. The resulting 
fluorescent produce after hybridization was explored and digitized using gene pix pro software. 
Data was normalized with two methods named as 1) within array control method 2) with whole 
negative control array. Log 2 fold change was calculated. Significant testing was also performed. 
Detecti V software was used to perform these tasks.  
Results: 
Detected viral species were arranged according to their log2 fold change. The higher log 2 fold 
change indicated the abundance of viral species in sample. More over graphs and figures were 
also drawn to indicate the detection of viral species. Significant testing indicates the presence of 
high level viral families according to their p-value and t testing.  
Conclusion: 
Detectichip can successfully characterize viruses frequently found in clinical samples. By 
applying both normalization method it can be stated that this detectichip able to identify broad 
spectrum of viral family, viral species, bacteriophages, plant virus. The likely viral RTI were 
adenovirus , influenza virus, rhino virus. The rare virus associated with RTI was human 
papilloma virus and mammalian orthoreovirus. This chip confirms that in sample 1 adenoviridae 
family was significantly present where as in sample 2 the likely specie is Influenza . 
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1-Introduction  
1.1. Respiratory tract Infections 
 Acute respiratory tract infections (RTI) are leading causes of childhood morbidity and mortality 
worldwide, resulting in nearly 2 million deaths annually
3-5
. The worldwide disease burden is 
estimated at almost 98,000,000 disability adjusted life years (DALYs) and more than 4,000,000 
deaths per year
6
. Even in the Western World, RTI contributes more to the disease burden and 
health care costs higher than any other infectious disease. Despite its abundance and potential 
severity, we still have limited information about causes, pathophysiology and the best ways to 
treat various RTI. In children, more than three-fourth of all RTI is caused by viruses
7,9,10
 and 
today over 200 various respiratory viruses are known. Nevertheless, in recent studies on 
childhood RTI, despite the use of comprehensive diagnostic approaches more than one fourth of 
respiratory samples are virus negative. Thus, it is likely that more respiratory viruses do exist, 
but they may escape detection from present diagnostic tests.  
Respiratory infections can be termed according to the area of involvement, namely upper 
respiratory tract infections and lower respiratory tract infections. In children with RTI, a likely 
pathogen (virus or bacteria) may be detected in respiratory secretions from the upper airways
15
. 
Initial symptoms of upper respiratory tract infection are coryza, cough and hoarseness
16
. Rhinitis, 
laryngitis, pharyngitis (sore throat) are commonly observed. These are infections of 
nasopharynx, larynx, tensile, sinuses, ears
17
. Lower respiratory tract infections refers to 
infections of the trachea, bronchus, and alveolus, results tracheitis (causing hoarseness, painful 
breathing in and out
17
), bronchitis, bronchiolitis,  bronchopneumonia asthma exacerbations, acute 
otitis media as shown in figure below
18
. Lower respiratory infections are generally more severe 
than upper respiratory infection
17
. e.g. when infection results in necrosis of epithelial lining the 
bronchioles, it can spread to lungs causes bronchiolitis and pneumonia
17
. 
Virus infection starts when sufficient viruses are available, site of infection is permissive to the 
virus and local host antiviral defense system is ineffective. Viral pathogenesis is the result of 
molecular interactions between the cell and virus. N-acetyl neuraminic acid, glycosaminoglycans 
and glycolipids, ICAM integrin receptors and molecules of the Major Histocompatibility 
complex are involved in interactions with epithelial cells of human respiratory tract. 
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 Some viruses require co-receptor molecules to penetrate the cell e.g Adenovirus. Respiratory 
viruses are mainly transmitted by direct contact with the contaminated secretions
19,20
, aerosols or 
fomites (objects or surface. Most viruses that infect humans enter into the body through the 
respiratory tract as aerosols produced by coughing. Sneezing is a source of discharging droplets 
containing virus particles and leading to initiate the infection. Large viral particles are usually 
trapped in the turbinates and sinuses and could cause upper respiratory infections. Smaller viral  
particles can reach the alveolar spaces and cause infections in the lower respiratory
11
. 
 
 
 
 
 
 
 
 
 
1.1.1. Respiratory Tract Infection pathogens and prevalence of infection: 
Several bacteria, viruses, fungus, and other pathogens are the source of respiratory  tract 
infections (RIs)
21
. Influenza virus type A, B, C, Para influenza virus type 1,2,3, Respiratory 
syncytial virus (RSV), Adenovirus and Rhino virus are the most common cause of RTI
22
. 
Laryngitis is mostly caused by Para influenza virus
17
.   
In recent studies about pediatrics respiratory infections, more than one-fourth of respiratory 
samples are virus negative. Earlier studies also hypothesized that no etiological agent can be 
identified in ∼30% of patients suffering from respiratory disease due to unknown viruses6. With 
Figure 1: The Respiratory tract infection caused by viruses: Viruses can infect the upper 
respiratory tract occasionally some of them can cause infections in the lower respiratory 
tracts. Others enter through the respiratory tracts but they move to other organs. This figure 
is adapted from 
11
. 
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regards to prevalence of viruses in several western countries the data revealed that adeno virus 6 
strains (A-F) prevalence is approximately 2-14%
23
. Human metapneumovirus have been 
discovered in the Netherlands in 2001
24
, affecting mainly children less than 5 years
25
 and causing 
both upper and lower respiratory tract infection
26
. Corona virus accounts for 5-30% virus 
infection. Human Bocavirus was discovered in Sweden in 2005 with prevalence approximately 
2-11%
27
. 
Table 1: Respiratory tract Infections (RTIs) pathogens: Studies reflects the mechanical disorder due 
to major viruses, families, types. Majority of the respiratory tract infection viruses are RNA viruses. 
This table is modified from
17,22,28
 . 
1.2. Conventional diagnostics methods 
Respiratory tract infection viruses diagnosis began in 1933
29
. In vitro culturing methods have 
first been used to diagnose respiratory virus infection
22
. Propagation of viruses in culture is 
Virus family Viral agents 
Virus 
types 
Nucleic 
acid 
Disease type 
Orthomyxoviridae Influenza A and B Several RNA Acute Bronchitis 
 Parainfluenza 1,2,3,4 RNA Laryngitis 
 Respiratory syncytial virus 1 RNA Bronchiolitis, pneumonia 
Picornaviridae 
Rhinovirus Several 
RNA Bronchitis 
 
Enterovirus 
 RNA  
 Coxakievirus (24 types) 
A21 
RNA Upper respiratory infection 
 Echovirus(34 types) 11,20 RNA  
Coronaviridae Human corona virus  0C43 RNA Bronchitis 
 Human corona virus  229E RNA Bronchitis 
 Human corona virus  HKU1 RNA Bronchitis 
Adenoviridae Adeneovirus(41type) 
5-10 
types 
DNA 
 
Pharyngitis, Bronchitis 
Parvoviridae Bocavirus  DNA  
 Polyomavirus WU/K1  DNA  
 Parvovirus  DNA Lower respiratory infection 
Paramyxoviridae Human metapneumovirus  RNA  
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visualized by morphological changes termed as cytopathic effect
9
. These effects can be observed 
by microscopy.  
 Primary monkey kidney cell lines are usually used for isolating respiratory viruses
9
 (vero cells). 
Some viruses are not culturable in vitro, i.e human bocavirus and human corona virus
6
. It might 
take 10 days or more to develop a cytopathic effect. Delay in achieving results make tests  
laborious to work with
16
. 
Serological methods are based on the rise in antibody concentration (usually increase IgG 
responses) in infected host
6,16,28,30
. Hemagglutination test (HIT), complement fixation and 
immunoassays (EIA) belong to those serological methods. Two weeks are usually required to 
develop antibody response in infected host
16
. Antigen detection methods are particularly useful 
for those viruses which require long time to propagate in cell culture such as respiratory 
syncytial virus, parainfluenza viruses, adenoviruses. However these methods are not useful for 
detecting those viral species that have antigenic heterogeneity e.g. rhinovirus
9
.  
Serological methods give results rapidly, e.g. direct florescent antibody staining tests (DFA) give 
results in 3 hours.  In this DFA technique fluorescein labeled antibody detect pathogenic antigen 
and immunofluorescence pattern can be observed with microscopy
19
. In general, those 
conventional methods have low sensitivity and specificity and hollowistic view on viral flora is 
not give.  These methods do not show global picture
31
. 
Microscopic diagnosis is also useful but to some extent. It is used to diagnose inclusion bodies. 
But the presence of these inclusion bodies is not true for all respiratory tract infection viruses. 
Electron microscopy is useful as it reveals presence of virus particles in patient and investigating 
corona viruses. This is also helpful in identifying viruses from formalin fixed tissues if fresh 
tissue is not available.  Tissue preparation and increased detection time are disadvantages
28
 .  
1.3. Molecular diagnostic Methods: 
Molecular diagnostic methods are able to identify nucleic acids of specific pathogens in 
specimen
30
. Molecular methods are important as these methods deals with the genes. Whereas 
conventional methods works  on basis of phenotypic characteristics. 
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 The development of polymerase chain reaction provides a rapid and sensitive method, but 
requires for testing specific pathogens that we know before. This technique allows the 
amplification of single or multiple copies of DNA to produce thousands of copies of DNA by an 
enzyme-reaction (shown in figure 2). The major disadvantage of PCR is that it is unable to detect 
novel viruses.   
 
Figure 2: Principle of polymerase chain reaction (A) Major steps of PCR (B) Exponential growth of 
amplicon in the PCR amplification
32
. 
 
PCR is based on the thermal denaturation of double stranded DNA and the specific annealing of 
oligonucleotides (primers) at the 5'- and 3' end of the target DNA area. These oligonucleotides 
become elongated in the extension phase by a DNA-dependent DNA polymerase, using free 
deoxynucleoside-triphosphate (dNTP) .This process take place in a thermal cycler and the 
temperature profile is repeated until enough copies of the target sequences are produced, e.g. 30 
cycles produce theoretically Each PCR must be adapted to the actual application. Some 
important parameters are: 
• Primers 
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To find the approbate primers for the target is a crucial point for using PCR as detection method. 
The first step is to find a conserved target sequence of a defined length unique for the organism. 
Primers are usually 12 – 50 bases in length. Depending on the base composition of the primers 
the annealing temperature (TA) is calculated. The optimal TA is defined approximately 5 °C 
lower than melting temperature (TM) of the oligonucleotides
33
  
TM = 4 • (G+C) + 2 • (A+T) only valid for oligonucleotides up to 20 bases ! 
• Polymerase 
A broad variety of available DNA polymerases exists and can be chosen depending on the used 
PCR technique. For PCR as detection method, a thermostable polymerase with 3' → 5' nuclease 
activity, allowing the replacement of incorrectly integrated nucleotides (proofreading function), 
is useful. To avoid unspecific annealing and polymerase activity at room temperature, the use of 
a so called Hot-start polymerase is an advantage. Hot start polymerases become active only after 
an activation step of 10 minutes at 95 °C. 
•Number of cycles 
The number of cycles necessary to obtain a sufficient amount of an amplicon depends on the 
concentration of the DNA template. Usually 30 – 40 cycles are enough to get a good detectable 
result The extreme sensitivity of PCR may also be a disadvantage, because of the ability to 
generate millions of copies from one single template. Thus, a contaminating DNA template can 
produce a false positive result. The risk of contamination can be reduced by the physical 
separation of the reaction preparation from the area of reaction product analysis, use of negative 
controls, use of pipette tips with barriers preventing contamination. 
1.3.1. Other PCR methods: 
In Reverse transcriptase PCR RNA target first reverse transcribed in to cDNA.  
Nested PCR uses two pairs of primers for two rounds of PCR.  
If multiple primer are used in PCR amplifying different targets then it is known as multiplex 
PCR
34
.  
Real time PCR can be modified as quantitative PCR as the sample which has high a viral load 
will be amplified sooner as compared to sample with low viral load
34
. Real time PCR allows 
more sensitive quantitative detection by florescence detection technology.  
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FRET (fluorescent resonance energy transfer) probes, dual hybridization probes that are 
sequence specific probes are used in Real time PCR which are mixed with PCR reaction 
mixture
35
. PCR amplification can be monitored as the probes react with the PCR product to give 
an increase in the fluorescence signal
34
.  
Random PCR uses a primer that has unique universal sequence at 5' and at the  3' end contain 
hexa or heptamer sequence. A second primer is complimentary to first primer  universal 
sequence 
34
. 
1.3.2. Other nucleic acid based methods 
Loop mediated isothermal amplification is a technology that does not require thermal cycling. 
Amplification of sample can be carried out at a single specific temperature.  
Sanger sequencing is the conventional method of sequencing DNA. It is based on chain 
termination method. The Basic principle is that in four separate reaction mixtures, DNA template 
, dNTPs, DNA polymerase, and dideoxy nucleotide triphosphate is added. The later would 
terminate the synthesis of corresponding fluorescently labeled dNTP results termination of 
extension 
36
.  
1.3.3. Requirement of new diagnostic method: 
Some viruses escape from the detection with diagnostic method. There is a need of new 
diagnostic method.  
Next generation sequencing techniques reveals unbiased and in-depth information but is 
expensive
37,38
. High throughput method such as 454 (roche), Solexa (Illumina), or SOLid (Life 
technologies are useful for metagenomic analysis. Millions of unbiased sequences can be 
obtained
38
  
Another hightroughput technology is microarray technology, which will be described in deep 
below.  
1.4. Microarray technology as advanced diagnostic method 
Nucleic acid based methods complementing conventional methods, such as immunological 
assays, biochemical and culture based assays. However those conventional assays are 
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monoparametric (determining single parameter). In contrast to that microarray technology, 
performs a multiparametric assays
39
.  
The first report on detecting viruses by using microarray technology was published in 2002
40
. 
Southern blot and dot blots are known as radio labeled macroarrays. Those macroarrays 
comprise larger size spots of 300 microns, where as in microarray sample a spot is less than 200 
microns
31
 A microarray is a collection of specific DNA probes on miniaturized device to produce 
either quantitative data or qualitative data
31,37,41
. Thousands of molecules are analyzed in a high 
throughput fashion to see global picture of system under study
31
. The position of particular 
probes is designated as features or spot
42
. 
Genotyping to analyze the genomic DNA for characterizing viruses can be done with the help of 
microarray technology and can therefore be used as genomic sensors
43
.  
Microarrays are divided into several categories depending upon density, number of probes, 
length of probes, number of dyes, and type of target as well as on the material used for 
depositing probes.  
High density arrays contain thousands to millions of spots. Those arrays are not yet used for 
daily laboratory practices. 
Low density microarrays contain few hundred to thousands probes and are used for in vitro 
diagnostics of viral pathogens
39,44
.  
 Double stranded DNA microarray comprise of PCR product, or cDNA which have high 
sensitivity and low specificity and  lack palindromic sequences
41
. Oligonucleotide microarrays 
consist of 25 to 80 nucleotides rather than the whole gene
43
.  
Protein microarray, tissue microarray, cell microarray are other types of array
31
 but DNA 
microarray array is the most widely used type
42
. 
Microarray technology focuses on high throughput analysis for pathogen detection.
45
, identifying 
pathogen viability
45
, enumerating pathogenic agents
45
, antimicrobial resistance monitoring and 
strain typing. Therefore microarrays are good diagnostic platforms
41
 for public health  medicine 
and veterinary diagnostics
45
. Microarrays occupies a place between low cost multiplex PCR and 
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expensive high throughput sequencing technologies
37
. It was reported that microarray identified 
pathogen with 94% accuracy (76% sensitivity and 100%specificity) in 36 patient specimen
46
. 
Cost of a microarray is approximately 100-500 dollars
38
. 
The target molecule is labeled with fluorescent dyes and gives  a signal upon hybridization
47
.  
Indirect fluorochrome labeling increases the sensitivity of detection
40
(details are given in 
labeling sample section) . Microarray were scanned at 5 um resolution through agilent scanner
46
.  
Arrays can be divided into subarrays allows testing of multiple samples on one slide. Duplicate 
spots  are also act as control
43
. Spotting same probe several times on array is a kind of replicating 
the array
42
. The replication  is important to have back up in form of duplicate spots and for 
improving data quality
42
. In this present study 2 glass slides contain two subarrays each with 
105000 probes.  
Sequence recovery is required for obtaining novel virus sequences for emerging infectious 
diseases
48
. It can be done by putting 100 µl of water at 90°C to array. Recovered eluate amplified 
with specific primer, cloned with plasmid vector. After transformation colonies are screened by 
sequencing
49
.  
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1.4.1. Design of microarray experiments:  
 
 
 
1.4.2. Probes characteristics 
Probes are short nucleic acids with a known sequence and identity
50
. These sequences are 
frequently selected from nucleotide sequences found in the 3’end of the transcript47 . There are 
two types of probes , gene probes and oligonucleotide probes. Gene probes are longer than 500 
nucleotides and require a whole gene sequence which is obtained from Genbank, EMBL or 
DDBJ sources.  Longer probes provides  more sensitivity and increase hybridization strength but 
are less specific 
41
 because they might bind randomly to potential target sequences. Appropriate 
probe length is critical to determine 
41
.  
Figure 3: Flow of microarray experiment: Begins with a microarray design. In first step 
microarray chips are printed. Sample is extracted labeled with fluorescent dye , hybridized 
to microarray. It is than scanned to acquire fluorescent image. Image analysis is 
performed to get raw signal data. Raw data is further normalized. Statistical tests are 
performed and meaningful data is interpreted. 
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Oligonucleotide probes targeting specific sequences with in a gene. They detect genes with slight 
differences in sequences. This will prevent hybridization to closely related sequences
51
 .Usually 
0.1-1nano liter probe is spotted on the slide
47
.  
Conserved regions (highly similar sequences) are generally used for probe design. The reason is 
that probes specific for a given genus but not with other genera can discriminate between the 
intended target and all other target
52
  
Oligonucleotide probes should have 40–60% G-C, without complementary regions and repeats 
of more than four single base should be avoided. For probe designing amino acid sequence 
conservation is also utilized
53
.   
1.4.3. Logic of finding known and novel virus on  viro chip:  
Viral genome consists of variable and conserved regions. The latter have not changed much 
during evolution, whereas variable region are constantly changed. Variable  regions are used for 
distinguishing viral strain of same species
12
.  
Virochip detect known and novel viruses by conserve sequence homology. It was reported that 
probes designed with conserved sequences within a pathogen genus or family and help in 
determining those pathogen in disease of ambiguous etiology
40
 and reveal novel viruses within 
the same family
37
.  
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1.5. Microarray platforms for printing slides: 
 Different platforms are using different materials for printing the microarrays (e,g, glass, silicon). 
Glass materials provides non porous, transparent, stable, rigid material that allows fluorescent 
detection, less background fluorescent and efficient kinetics during the hybridization
41,47
. 
Physical delivery techniques such as inkjet or microjet printing  are used for depositing probes 
on high density microarray
54
. Printing and insitu synthesis are two major methods for depositing 
probes on materials
31
. Examples are given below 
1.5.1. NimbleGen Systems 
This system employs maskless photo mediated system for printing microarrays
41
. In this 
technology virtual masks are produced with the help of a digital micrometer device for creating a 
Figure 4: Concept of finding known and unknown viruses using probes sequences: Figure A: 
indicates generalized map of a virus family represented by 4 virus species. Each virus species have 
conserved and variable regions. 6 spots in figure B-F represents probe of unique sequences. Figure 
C:  After putting unknown sample 1 on these spots, green fluorescence will be given after activation 
by laser. One can conclude that unknown sample is Virus A because it contain family a1 conserved 
sequences and virus A variable. Figure D: But if unknown sample shows a type of hybridization in 
which a1, a2, B1, B2 sequences show fluorescence it means this time sample contain virus type B. 
Figure E: If the hybridization pattern gives fluorescence at a1, a2 which are the conserved 
sequences present in known viruses but variable sequence did not match any known viruses and 
indicate that virus is new member of the same family. Figure F: If the fluorescence is present in a1, 
a2, B2 position than it  can be concluded that  sample contain virus of same family but it will be a  
new virus that is more closely related to virus B but not a  virus B  Figure G: If expanding the spots 
on chip to 12 and if the fluorescence is observed on a2, D1, b2, b1. Results indicate a new virus 
formed between recombination between virus A and D . These figures are modified from 
12
.  
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U.V pattern. On the microarray surface there are nucleotides containing photo labile protecting 
groups. The protecting groups are removed after exposing to UV light. This allows synthesis of 
60 to 100 nucleotides as shown in figure below. 
 
 
 
 
 
 
 
 
 
1.5.2. Affymatrix  
This platform synthesizes oligonucleotide in situ chemically on a quartz surface by  
photolithographic technology
55
. Oligonucleotides of 25 bases fabricated directly on to the surface  
by masking, light exposure and coupling of  oligonucleotide
56
. After hydroxyl group attached to 
glass slides, linker groups were also attached to photoliable groups. These groups are deprotected 
after exposure to U.V light allowing addition of nucleoside phosphoramidite monomer
54
.   
1.5.3. Suspension bead array  
This is a type of three dimensional array consist of beads as solid support.  Different sets of these 
beads are created with unique ID, contain different red to infra red ratio. Targets are amplified 
with biotinylated primer and than they hybridized to microspheres. The interaction can be 
monitored with flow cytometer. 
41
.  
Figure 5:  General principles of NimbleGen oligonucleotide microarray: light deprotection 
and nucleotide addition as shown. 
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1.5.4. Electronic microarray 
This type of microarray controls nucleic acid transport by active hybridization via electric 
current.  Complementary semiconductor technology is  use for electronic addressing of nucleic 
acid. The negative charged nucleic acid hybridized with positively charged test sites Advantages 
of this technology is multiplexing, minimum waste production, low cost. This is sufficient for 
majority diagnostic approaches 
41
. 
1.5.5.  Agilent technologies  
The Agilent platform utilizes inkjet technology for synthesizing and spotting the probes on 
slides.
41
 There is no need for lithographic or digital masks. Synthesizing 60mer oligonucleotide 
accomplished by using five ink (4 bases plus catalyst) and involves coupling and deprotection 
step
41
. Phosphoramidite chemistry maintains coupling efficiency for the synthesis of full length 
oligonucleotides directly on the surface on the microarray 
50,56
. 
 Digital sequence files allow pico liter spotting of oligos base by base. Formats of agilent 
microarray slides are 1x244000probes, 2x105000probes, 4x44000probes, 8x15000 
probes,8x60000 probes. In the present study 2x105000 probes  format was selected which means 
that slide contain 2 subarrays and each have probes of 105000 probes 
 
 
 
 
 
 
 
 
 
Figure 6: Oligo synthesis mechanism via inkjet printing: The first layer of 
nucleotides is deposited on the activated microarray surface. B: growth of the oligos is 
shown after multiple layers of nucleotides have been precisely printed. C: close-up of 
one oligo as a new base is being added to the chain, which is shown in figure D. adapted 
from
8
.  
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1.6. Target or sample preparations: 
A "target" is the free nucleic acid sample whose identity and/or abundance is being detected
50
. 
Different platforms follow different methods for amplifying the target. Target amplification is 
required for clinical samples, because the concentration of viruses are often below the detection 
limit in clinical samples 
57
.  
One of those method is Random phi 29 amplification generate enough viral material for 
hybridization
57
. However this method can not amplify short DNA or RNA fragments. A 
preliminary step for detecting RNA viruses requires whole transcriptome amplification to 
produce cDNA fragments. This cDNA can be efficiently amplified by Phi29
57
 . This phi 29 
amplification was used to amplify targets  in Lawrence Livermore microbial detection 
array(LMDA) platform which is described later 
57
.  
Random PCR amplification is a broader approach for amplifying high density arrays 
34
. This 
has an additional advantage to identify unknown pathogen
46
. Majority of RNA viruses lack 
polyA tail therefore it is advantageous to use random primer.  
1.7. Sample labeling:  
Samples can be labeled with different florescent dyes, mixed and hybridized to probes on the 
array. Measured fluorescent intensity is proportional to abundance of target. Therefore equal 
labeling per molecule is important.    
The most commonly use dye for direct and indirect labeling are Cyanine-3 (Cy-3) and Cyanine-5 
(Cy-5) dyes. They act as reporter molecules because they indicate the presence of cDNA.  
Because Cy-3 and Cy-5 are light sensitive it is important to perform all working steps in the 
dark, to prevent degradation of dyes. Cyanine dyes gives  intense strong fluorescence as these 
dye will not bind to the chip
42
. Three major labeling methods are 
1.7.1. Direct labeling method: 
This method involves the enzymatic incorporation Cy-3and Cy-5 labeled dCTP and dUTP in the 
target. In addition dATP and dGTP are also added. Major disadvantage is the inherent bias due to 
presence of different sizes of Cy3 and Cy5. The rate of labeled nucleotide incorporation is not 
same
56
. 
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 1.7.2. Indirect labeling method: 
Indirect labeling involves first incorporates modified nucleotide sequence, that is aminoallyl 
linker followed by labeling with fluorescent dye. Rate of incorporation will be the same for 
modified and unmodified dNTPs and thereby avoiding the bias
56
. The modified dNTP amino 
group reacts with the NHS of mono reactive Cy-3 dye 
42,47,58
.  
 
 
 
 
 
 
 
 
1.7.3.  Indirect dendimer labeling method:  
 The dendimer is complex nucleic acids branched structure comprise of hundreds of fluorescent  
molecules. Greenchip established indirect dendimer labeling method
59
. The dendimer method 
requires very less amount of RNA
60
.  
1.8. Hybridization: 
The process of binding probe and target is known as hybridization
47
. Classical or automatic 
procedures are adopted for array hybridization. 
42,56
. The details are described in material and 
method section.  
1.9. Scanning   
To measure the fluorescent signals scanning is an important step. It is done with scanner at the 
particular resolution
42,56
. The details are given in material and method section. 
Figure 7: Indirect method of Cy 3 dye incorporation: In step 1 aminoallyl dUTP is 
added. Fluorescent dye attached to amine  group modified in the second step. This 
figure is modified from
1,2
. 
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 1.10. Previous developed virus detection arrays:  
1.10.1  Virochip: 
Chen et al. developed a panviral microarray assay named virochip to detect known and novel 
viruses
37
. The 70 mer sequences unique to a taxonomic family fabricated using agilent ink jet 
array platform
37
. This platform detect novel viruses SARS coronavirus, rhinovirus clade, 
retrovirus associated with prostate virus called XMRV, avian borna virus causing wasting 
disease in parrots, cardiovirus in children associated with respiratory and diarrheal illness. 
Present version of virochip is composed of 36.000 viral probes. These probes are formed from 
1500 viruses present in genbank in 2009
61
. 
In virochip probes are designed by sequence derived from multiple genomic regions Due to the 
legth of probes 70 mers. It is tolerant for sequence mismatch
62
. 
1.10.2.  Resequencing pathogen microarray: 
This pathogen detection arrays is based on affymatrix arrays. For each target gene 4 sequence 
probe of legth 25 to 29 nucleotide is selected. This platform is for tropical and emerging  
agents 
37
. 
1.10.3.  GreeneChip 
 GreeneChip Vr has been developed for detection of targeting respiratory viruses
38
. This is a high 
density array based on Agilent ink jet system. 
 Greene chip pm version 1 composed of 9477 probes for viruses. GreeneChip vr is extensively 
reviewed in
49
 composed of 29495 60 mer oligo. Probe sequence was selected in a way that they 
cover viral species present in gen bank allowing five or fever mismatches 
37
.  
1.10.4.  Lawrence Livermore microbial detection array: 
It is the most comprehensive array to date. Probe lengths between 50 and 65 nucleotide. This 
array is based on maskless photo mediated system. This platform is able to identify viruses and 
bacteria. The conserved sequences with in the family were used for probe designing. 10 to 50 
number of different probes were selected for each microbial genome sequence
37
. 50 sequences 
per virus and 15 probes per bacteria were made as compared to other chips in which less probes 
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er targets were designed
38
. Version 1 of chip contain only viral sequence, second version 
designed with viral and bacterial probes
38
.  
2-Objectives 
For applying the best possible treatment it is however important to answer the clinical question: 
which pathogens are present at the disease site, how important is the presence, and which 
influence has this presence on the microbial ecology and subsequent pathogenesis? Lacking this 
information only imperial therapy is possible, which may not be effective or even 
contraproductive (the unnecessary use of antibiotics).Therefore to answer the question of who is 
present and who is why responsible for given infectious respiratory disease, a good diversity of 
viral population that contribute to pathology is require, to know relationship between organism 
and disease and to prevent secondary spread of infection. The advanced diagnosis is requiring for 
characterizing viral diversity for this purpose high through put technology DNA microarray was 
used as a diagnostic tool. 
 The major goal is to identify broad panel of respiratory viral pathogen in clinical samples 
of pediatric respiratory tract infection by applying microarray technology as a diagnostic 
tool.   
 To be able to understand  DNA microarray technology 
 To visualize the   global picture of detected pathogen by using software. 
 Minor aims include gain experience in the planning and performing research experiment. 
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3- Material and Methods: 
 3.1. Place of work: 
 To work with respiratory tract infection biosafety 2 level facilities are required. This level is 
appropriate for working with agents that causes hazards to individual and the environment. Initial 
steps were carried out in BSL-2 safety levels faculty of medicine, NTNU. Final steps of 
experiment were performed at NTNU Cell & Molecular Biology laboratory in Trondheim. 
3.2. Experimental stages:  
Experimental work done in this study can be described in three stages. 
1) Design of specific microarray-detectichip 
2) Sample preparation 
3) Data analysis 
3.3. Design of specific microarray-detectichip: 
3.3.1.Name of my microarray chip: 
Microarray designed for this particular work is based on Agilent platform. The name given to 
this microarray was detectichip because this chip was able to detect viruses through detecti V 
software so I gave the name to the chip as detecti chip.   
3.3.2. Technology used: 
Detectichip that is microarray chip contains desired probes sequence was printed from Agilent. 
The reason for selecting Agilent as platform is its reliability, good service by its product 
engineers and moreover the scanner in NTNU is of Agilent which can be used for scanning 
printed slides from Agilent.  
3.3.3. Probe selection: 
Probes were selected from Geodata base. The details of Geodata base is given below.  
3.3.4. Gene expression omnibus 
The Gene expression omnibus (GEO) launched by NCBI is a public repository for storing and 
maintaining microarray data. 
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3.3.5. Data retrieving  
Data in GEO consist of platform, sample, series, and raw data with their proper accession 
number
63,64
.  
 GEO Platform (GPLxxx) : Provides a probe list. 
GEO Sample (GSMxxx) : signifies a set of the molecule being probed.  
GEO Series (GSExxx): Arranges samples into meaningful data that make up an experiment.  
GEO Data set (GDSxxx): Reassembled data from geo staff.  
Data can be downloaded as Simple Omnibus Format in Text (SOFT) format or viewing as Hyper 
Text Marke up Language (HTML)
65
. SOFT format contains data table and descriptive 
information in form of text and matrix format. SOFT matrix is arranged in excels sheets.  
3.4. Searching for probe sequences: 
Different platforms were observed for selecting probe sequence. 
1-MegaViro platform (GPL1834), contained ~11,000 oligonucleotides were first observed. But it 
was rejected because it contains less probe sequence relative to other platform.  
 2- Platform (GPL3429, Viro3) was than selected for probes sequences. As these probe 
sequences were specifically designed for pediatric respiratory tract infections containing~22,000 
oligonucleotides derived from ~1200 viral species. But again this probe sequence selection was 
rejected because these sequences were of 70 nucleotide long. Agilent technologies stop 
producing 70 mer long probes. There was option to select another platform if agilent will not 
print the slide or if these probes from another platform should be selected so that agilent can 
synthesize detcetichip. So this viro 3 probe platform was not selected due to technical reasons.   
3.5. Obtaining required probe sequences from Geodatabase: 
The other platform (GPL13407) was selected. This is a subcollection of larger array describe in 
an article from Gardner et al
38
. The reason for choosing this platform was its ability to detect 
viruses and bacteria. Majority of probes were of 60 nucleotide long. Some of the probe 
sequences were also of more than 60 mer sequences. These probes were modified by deleting the 
nucleotide from the edges. This was just to make the compromise to keep those probes on the 
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array. This platform provide 58131 probe sequences containing 33263 unique probe sequences 
out of which 24868 are redundant. These unique probes consist of specific sequences 
representing virus families, nonconforming sequences (not associated with family ranked 
taxonomic node), bacteria, plasmid, human and random control sequences
38
. 
After selecting the required probes the next step was to deposit that probes on chip. For this 
purpose Agilent technology was used.   
3.5.1. E-array for ordering the detectichip 
E array is a web based tool was used to create a microarray design for uploading probe. This tool 
consists of 5 major steps for uploading probes.  
1) In this step probe parameter and file details were set out. The details about handling the 
uploaded probes and to set the probe parameters were specified. Appropriate format was 
selected. Either MiNIML abbreviation format or complete format is chosen.  MiNIML 
format consist of probe ID column and Probe sequence column.Complete format contains 
seven column. The files are uploaded were uploaded in  xls format.  
2) Probes were uploaded and previewed 
3) After uploading probe design were defined. Microarray name type such as spotted 
oligonucleotide arrays and the format of 2 ×105000 probes was selected. This format 
means that one glass slide will contain 2 subarrays, each subarray will contain 105000 
spots. Duplicate probes were selected due to enhance quality control measures Linker 
sequences were also added. These sequences are added for those sequences which are 
shorter than 60 nucleotides. Moreover the purpose of these linker sequences are to 
decrease steric hindrance and make probe sequence available for target sequences.  
4)  Layout of probes is selected in which positive or negative control probes are added.  
5) Finally microarray  design was saved and ordering details were received36.  
3.5.2. Agilent technologies printing the  detectichip:  
Different platform follows different methods to fabricate oligonucleotide on chip. For example, 
Affymetrix uses 25-mer, MWG uses 50-mer, Agilent uses 60-mer, Operon uses 70-mer, and 
Clontech uses 80-mer for their oligonucleotide microarray fabrication. Photolithographic 
approaches followed by Affymatrix platform synthesize oligonucleotide on silicon wafer. 
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NimbleGen systems utilize Maskless Array Synthesizer (MAS) technology to fabricate 
oligonucleotide on glass slide (Principles of each technology is given in introduction part of 
thesis).  
Ink-jetting  printing technology has also been used to synthesize oligonucleotide probes on the 
microarray by Agilent. Printing can be done with robotic devices contain pins 
66
.This 
technology  fabricates 60 mers oligonucleotide probes base by base that are present in digital 
sequence files enabling politer of spotting. Phosphoramidite chemistry maintains coupling 
efficiency for the synthesis of full length oligonucleotide
8
. 
After probes were successfully uploaded the next step was to fabricate detectichip done by 
Agilent. Detectichip is an array encompassing probe sequences of 60 mer synthesize by Agilent 
technologies. Spotted oligonucleotide microarray was chosen for array fabrication, because this 
technology provides multiplexing, rapid, cost effective, unbiased detection of infectious agents 
that leads to higher sensitivity and specificity. The basic difference between spotted 
oligonucleotide and cDNA microarray is the probe length. Oligonucleotide probes are shorter in 
length in contrast to cDNA nucleotide.  
3.6. Sample preparation: 
Two Clinical samples were obtained from nasal swabs of hospitalized children. One was  sample 
1 (known for adenovirus presence). Second sample was sample 2 (unknown). Target sequences 
present in clinical samples were randomly amplified with random primers. The details are given 
below.  
3.6.1. Primers: 
Primers were synthesized by Eurogentec (Belgium). Oligo dt primer, random primer primer 
serve as starting point for the polymerase to add the bases to make up a strand complementary to 
the template. 
Oligo dt primer initiate reverse transcription at the  3'  end of poly A tail. Total RNA can be used 
as template material. Random primers are require to transcribe non polyadenylated RNA. These 
primers bind throughout the target. They are less likely to give 3'  bias in resulting cDNA
67
. 
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 In this study random primers are used because poly A tail are not present in the majority of the 
viruses. The random primers binds to multiple sites along the entire transcript to generate short, 
partial-length cDNAs
67
. The principle of random priming is described in figure below.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primer A sequence: 
 
Primer A Sequence 
 5'-GTTTCCCAGTCACGATA-(N9)-3' 
Primer B sequence:  
 5'-GTTTCCCAGTCACGATA-3' 
3.6.2. Reconstitution of Primers: 
Primers were obtained in lyophilized form and reconstituted in water. To make 100µM stock 
solution of Primer A 1.37ml water was added in vial. 40pmol/µl working reagent was prepared 
Figure 8: Principle of Random PCR: A primer  5' end with unique sequence indicated by wavy line and 
3'degenerate end sequence used in PCR reaction to amplify viral DNA. The degenerate part of the primer 
anneals to complementary sequence. The primer is extended using Ligase. Generated double strands 
separated by denaturation. A primer representing only unique sequences of the first primer is used for 
subsequent amplification of target sequences. figure is adapted from
14
. 
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by taking 40 µl stock and 60 µl water. Primer B was reconstituted first in 337µl water to make 
100pmol/µl concentration.  
3.7. Pretreatment and extraction of Nucleic acid: 
Qiagen Ultrasens Virus Kit (Heldin, Germany) was used to extract nucleic acid from nasal 
aspirate sample which were preserved in medium. The vials in kit based on Silica gel membrane 
technology to concentrate viral nucleic acid. The kit allows downstream detection of low viral 
titres, in contrast to other isolation kits.  
Briefly 0.8ml buffer AC (to inactivate RNAs) and 5.6 µl carrier RNA was  added to sample, 
incubated for 10 minutes  followed by centrifugation for 3 minutes to pallet nucleic acid.  Pallet 
was resuspended in buffer AR, Proteinase K and incubated for 10 minutes at 40°C to digest the 
protein. Buffer AB 300 µl and 700 µl cell lysate was applied to QIAamp spin column. The 
extracted viral nucleic acid binds to membrane after centrifugation. Washing was done with 
buffer AW1 and AW2. Pure nucleic acids was eluted in 60 µl buffer AVE and stored at -80°C. 
Extracted nucleic acid was treated with three rounds(A,B,C) of enzymatic reaction to amplify the 
target.  
Round A: cDNA was synthesized with the primer A and reverse transcriptase.  
Round B: specific primer B is used to amplify template of round A sample.  
Round C: Round B sample was further amplified target by PCR cycles followed by integrating 
aminoallyl dUTP 
68,69
. 
The details of these steps are given below: 
3.8. Reverse Transcription and First strand synthesis (Round A):  
Reverse transcription is a process of forming cDNA. This step of reverse transcription is required  
because extracted RNA is likely to be  destroy so reverse transcribed into cDNA is performed to 
get stable form of DNA
70
. Moreover most respiratory viruses are RNA. To detect RNA viruses 
this step is required.
67
.  
Characterizing viral diversity in Respiratory tract infection by DNA microarray technology 
   
 
Page 25 
 
  
First-strand reverse transcription was initiated with a random nonamer linked to a primer 
sequence. Briefly 1 µl (40pmol/µlit) Primer A (eurogenetec) and 4 µl extracted nucleic were 
heated to 65°C for 5 minute in a thermo T100™ thermal Cycler Bio-Rad followed by cooling at 
room temperature for 5 minutes. This step is require to eliminate secondary structure, primer 
binding and relaxing RNA.  
In above 5 µl of reaction mixture, 1 (10X) RT buffer , 1 µl (12.5mM) dNTP mix ( Promega, 
Madison USA), DEPC treated water 2 µl, SIII reverse transcriptase 0.5 µl (Invitrogen), 0.5 µl  
dithiothretrol (Invitrogen) was added followed by incubation in T100™ thermal Cycler Bio-Rad 
for 60 minutes at 42°C. At this temperature superscript III RT enzyme provide increase 
specificity and higher yield of cDNA . Reaction mixture was heated at 94°C for 2 minutes (to 
abort reverse transcriptase) in thermocycler followed by cooling at  10°C for 2 minutes. Then the 
reaction mixture was pulse centrifuged for 5 seconds.  
 SuperScript reverse transcriptase (S III RT) is the version of M-MLV RT that has been 
engineered to reduce RNase H activity and provide increased thermal stability. The enzyme is 
used to synthesize cDNA at a temperature range of 42–55°C, providing increased specificity, 
higher yields of cDNA, and more full-length product than other reverse transcriptase. 
SuperScript reverse transcriptase (SIII RT) is not significantly inhibited by ribosomal and 
transfer RNA, it is used to synthesize first strand cDNA from a total RNA preparation 
Dithiothretrol (DTT) is added to stabilize enzyme.   
3.9. Second Strand Synthesis: 
For second strand synthesis sequenase™ Version 2.0 (USB products, Affymatrix, Inc, USA) was 
used. It is a genetically engineered form of T7 DNA polymerase that has no 3'→5' exonuclease 
activity and is highly processive (incorporate nucleotides). In above reaction mixture tube 
sequenase mix contain (1 µl (5X) Sequenase reaction buffer, 3.8 µl water, 0.15 µl (13units/µl) 
was added and  ramp T100™ thermal Cycler Bio-Rad for 10 to 37°C. It was heated at 94°c for 2 
minutes followed by cooling to 10°C. The resulting product cDNA was stored at -20°C.  
 3.10. PCR amplification of randomly primed cDNA: (Round B) 
Polymerase chain reaction amplify DNA by denaturation, primer annealing, and primer 
elongation
71
. It is based on thermal denaturation of double stranded DNA and annealing 
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oligonucleotide at 5' and 3'. Nucleotide extension is done with polymerase. Thermo cycler 
maintains temperature profile to generate target copies.  
To randomly primed DNA, In PCR tube round A sample 5µl with 45 µl of master mix 
containing (5 µl (10X) Klentaq PCR buffer, 1 µl (12.5 mM dNTP mix (Promega, Medison 
USA), 1 µl (100pmol/µl) primer B (Eurogentec), 1 µl (50X) Klentaq LA enzyme (Clontech 
United States Canada),  and 37µlwater  was added.   
Klentaq LA is combination of klentaq-1 DNA with small amount of DNA polymerase which 
tends to increase fidelity, yield and length of product.  PCR protocol was run as follows: 94°C, 2 
min →(25 cycles of 94°C, 30 s / 50°C, 45 s / 72°C, 1 min) →72°C, 5 min →10°C (hold).After 
this round B sample was checked on 1.5% agarose gel.  
3.11. Agarose gel electrophoresis:  
This is a technique to separate 100bp to 25kb fragments. Agarose is extracted from sea weed
51
.  
Molecular sieving depends on pore size that depends on concentration of agarose. Higher 
concentration of gel smaller will be the pore size and smaller DNA fragments can be separated. 
Lower the concentration corresponds to larger DNA fragments separation. In this study 1.5% 
agarose gel was used. Gel was made in 40 ml 0.5X TBE. After adding 0.6 g agarose in 35 ml of 
0.5 ml TBE buffer. It was heated for 1 minute and incubated overnight or incubated for half an 
hour. Gel was poured in gel apparatus containing combs. After 30 minutes it was solidified and 
remove comb straight upwards and slowly. Then TBE buffer was added. Electric current was set 
at 60 minutes and 70 volts. 10X 2 µl loading buffer was added in 20 µl sample .Loading dye 
serves to concentrate and color the sample. After running the gel bands are appeared on the gel.  
Put that gel in gel red staining solution for 45 minutes followed with water for 5 minutes. DNA 
fragments of 765 bp, 880 bp 1022 bp were separated on a 1.5% agarose gel . The gel was 
exposed to UV light and the picture taken with a gel documentation system. After separation, the 
resulting DNA fragments are visible as clearly defined bands. The DNA standard or ladder 
should be separated to a degree that allows for the useful determination of the sizes of sample 
bands.  
3.12. Fluorescent dye incorporation (Round C) 
Fluorescent dye are mostly used for labeling purposes by following either direct or indirect 
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methods. Dyes are considered as reporter molecule because they indicate presence of cDNA 
bound to microarray.  Amarsham Cye 3 dye monoreactive (GE health care) was used in labeling 
experiment. It was resuspended in 45µl of DMSO and stored at 20°C. Labeling efficiency also 
depends on handling Dye. It should always wrapped in aluminum foil, providing dark by keeping 
sample in reaction box and incubating for appropriate time to prevent degradation. In this present 
study indirect method of labeling was used because rate of incorporation will be the same for 
modified and unmodified dNTPs.   
First aminoallyl dNTP (Invitrogen) mix was made containing aminoallyl dUTP.  Aminoallyl 
dUTP (AA-dUTP) is responsible for the production of amine labeled DNA. AA-dNTP mix was  
made (12.5mM 12.5 µl dATP,dCTP, dGTP),5 mM 5 µl dTTP and 15mM,15 µl AA.dUTP and  
water was added to make final volume 100 µl  in a tube. 1 µl aminoallyl dNTP mix was added in 
PCR tube containing 5µl of round B sample and 45 µl of master mix containing PCR buffer, 1 µl 
primer B, 1 µl Klentaq LA (Clontech United States Canada). PCR program was run as follows  
94°C, 2 min →(15cycles of 94°C, 30 s / 50°C, 45 s / 72°C, 1 min) →72°C, 5 min →10°C (hold). 
3.12.1. Cleaning of Round C sample 
DNA clean and concentrator kit from (zymogen) was used for cleaning round C sample. This kit 
is used for rapid purification and concentration of high quality of DNA from PCR and post RT 
cDNA clean up. In a 1.5 ml microcentrifuge 50 µl round C sample and 250 µl DNA binding 
buffer was added in to zymo spin column. Followed by vertxing. Mixture was transferred to spin 
column in a collection tube. Centrifuged and flow through was discarded. 200 µl of DNA wash 
buffer was added to column. This was centrifuged for 30 second. Washing step was repeated. 
Than 10 µl of DNA elution buffer was added directly to column matrix and incubate at room 
temperature for one minute. Column was transferred to a 1.5 ml microcentrifuge and centrifuged 
for 30 second to elute DNA. Ultra pure DNA is ready for further use. 1 µl of 1M bicarbonate and 
1 µl of Cy3 dye was added to the sample. Incubated for 1 hour in the dark. Cy3 labeled sample 
was again clean with DNA clean and concentrator kit by using the same kit.  
3.12.2. Measuring Dye incorporation: 
After indirect labeling the amount of dye incorporated in the sample was measured by using 
nanodrop before hybridization because it is helpful in setting up correct hybridization reaction. It 
was done using Nano Drop 1000 Spectrophotometer which allows measurements using 1 µl of 
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DNA or RNA. Appropriate value 6 pmol/µg DNA is recommended. It was determined using the 
formula below 
Dye incorporation= pmol/µl CY3 
                                 ng/µl (concentration of DNA in ug) 
3.13. Hybridization of fluorescently labeled target to detectichip:  
Hybridization is done in chamber contain slide. A spot indicates hybridization if sample contain 
a complementary sequence to that spot which is detectable in fluorescence. So every spot 
provides a way of independent assay. 
Master mix was prepared by blocking reagent 105µl and 21 µl fragmentation buffer. Than 
hybridization mix was prepared by 10µl round C sample, 85.5 µl water, 30 µl master mix, 125µl 
hybridization buffer. 250µl of sample of hybridization mix was loaded on to the gasket slide. 
Agilent printed detectichip array was placed on the above side of gasket slide (Agilent label 
facing down and its numeric barcode side should be up). Chamber cover was placed on this and 
thumbscrew was tighten and rotated in anticlockwise direction in order to wet the gasket slide. It 
was to be sure that detectichip is coated with hybridization mix. It was hybridized in oven at 
60C° at 10 rpm speed for 17 hours. Hybridization times in high ionic strength buffer and high 
temperature tends to increase hybridization mixing increases hybridization kinetics
47
. 
3.13.1. Washing array: 
Gasket/array slide was taken apart in gene expression buffer1 at room temperature.  Then it was 
washed in preheated buffer 2 for one minute. Slide was removed from buffer 2 in 5 to 10 seconds 
and it was placed in slide holder and insert into array scanner facing Agilent barcode facing up. 
Stringent washing is required in final washing steps. It is done by decreasing ionic strength of 
buffer or increasing temperature
42
. Stringent washing is done to remove cross hybridization
47
.  
3.14. Scanning   
Detectichip  is ready to scan after washing. Reporter molecule emits detectable light when 
stimulated with laser and its intensity was recorded. More bound spots give more intensity. 
Scanner might pick up light from other resources these comprise of some sample hybridized 
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nonspecifically, unwashed labeled sample might present on slide. Background is due to extra 
light. Agilent high resolution scanner was used for data processing. 
To measure the fluorescent signals scanning is an important step. It was done with scanner at 
5micro meter resolution scanner
42
 . Fluorescent signals might weaken with time so it is important 
to scan the slides immediately after hybridization.  
Laser is used to scan array. 150µm sized feature require 15um resolution
56
.  At 532 or 635nm 
scanner forms grey scale images in a lossless tagged image file format called TIFF file
56
. A 
major characteristic of most scanners are to select the color depth of 2 byte. This means that each 
pixel can assumes 65,535 different intensity levels
42
. Signal intensity corresponds to target or 
sample bound to spot
31
. As the diameter of spot is usually less than 200 microns in diameter. 
Most scanners resolution is 5 to 10 microns. This resolution gives the signal intensity upto 
hundred of pixels in 2D image file
31
. 
So maximum value for pixel will be like 2
8
-1=255, 2
12
-1=4095, 2
16
-1=65535 presented as 
dynamic range of scanner
31
.  
3.14.1. Image Analysis:  
Image analysis software places feature indicator in semi automatic or automatic manner. 
Manually controlling of the placement is preferably better
42
. Feature indicator consist of 
foreground and background
42
.  
Quantification of image data is done by calculating the mean or median of foreground and 
background intensity
42
. GAL file (gene pix array list) file is used to define features.  Image 
analysis software should differentiae a spot from its background, enabling quantification of  
overall intensity for each spot
31
. Many statistical programs machine learning  and visualization 
techniques are used in to make a biological sense of massive data 
31
. 
3.14.2. Gene pix pro software for scanning and analyzing arrays 
Gene pix pro software was used for scanning and analyzing arrays. Image of each Cy3 dye 
channel was saved as 16 bit TIF file. This data was extracted using Gene pix pro software. Some 
limitations are that data cant normalized and multiple experiment cant viewed. An image of array 
was loaded by opening TIF file. After loading the TIF file GAL (Gene array list) file was loaded 
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as shown in figure. Then gene pix result file (GPR) file was opened.  Spots which shows defects 
should be flagged (excluded from analysis). 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
         
 
TIF file 
GAL file (Gene array 
list) 
Figure 9: Loading GAL file on TIF  image array by load array list 
7
 
 
Figure 10: By using block mode : GAL file blocks combined with image 
indicated spot identification inside block
7
 
Fig 11: Spot identification inside each block: This figure indicated different spots 
such as saturated, unsaturated, absent, blank and undetected spot
7
.  
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Pixels were converted in spot intensities by using launch analysis option. These result files were 
saved as GPR (Gene pix result file) which was used further for analysis.  
4-Data analysis method 
4.1. Different data analysis software 
Data analysis can be done using different software. Below are the different software used by 
different platforms to analyze the data.   
4.1.1. Composite likelihood maximization: 
This algorithm is developed to analyze LLMDA data. But it can also be applied for virochip data 
analysis
37
. LLMDA chip data was analyzed using maximum likelihood method
57
. A forward 
selection algorithm was applied to find the most likely targets which are present in the sample. 
For pathogen analysis on array both positive and negative probe signals are also considered. 
positive signals above certain threshold allows pathogen detection
38
.  
4.1.2.  E- predict 
This software is developed for virochip data analysis. This  compares  probe intensity vectors for 
each array.  Comparison is done against theoretical hybridization free energy vector for each 
sequence in target database. Subsequent Pearson correlation coefficient done for normalization. 
E-predict edict identifies multiple targets using iterative statistics
38
. The major advantage to use 
E-predict is to produce quantitative reliable data. However this software package lacks 
visualization tools and work in unix/Linux platform
13
.  
 4.1.3. Greene LAMP algorithm   
Green lamp stands for Log Transformed Analysis of Microarray using P value to analyze greene 
chip data
37
. This assumes probe intensity should be normally distributed.  
This algorithm use BLAST alignments for assigning probes to target taxa. Probe intensity of 
each probe is determined with p value calculations   and Z test
38
.  
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 4.1.4. VIPR :  
This software stands for Viral Identification using Probabilistic Algorithm
37
. VIPR estimates on 
and off intensity distribution for each probe
37
. It is not designed to handle complex samples but 
can test for range of species
37
. VIPR estimated quantitative data for each probes. In context of 
my thesis this software is not used because the software is not able to handle complex high 
density arrays data of thesis.  
4.1.5. Phylodetect:  
In phylodetect software probe intensities are reduced to binary indicators. Scores are displayed in 
tree structure format, and therefore can be easily interpreted. However it is not designed to 
handle complex samples therefore not useful for high density arrays
37
. 
4.2. General Data analysis steps: 
Due to highthroughput technologies large amount of data is generated needing computational 
analysis. In general data analysis refers to obtaining raw data by image reading software (e.g. 
genepix), normalization and further identification of the targets.  
Normalized data of samples are compared with control samples to produce log ratio with P value 
calculations to determine its significance
72
. T-tests, ANOVAs, Gene Ontology (GO) 
overrepresentations, Bonferroni corrections, Fishers exact test are some examples of statistical 
methods used for complex data analysis
73
. In this study fold changes was calculated followed by 
T-test significant analysis to identify viral species in the sample. DetectiV software was used in  
this studies, steps are described below.  
4.2.1. Preprocessing (From image to numbers): 
Preprocessing is required to convert raw data to useful biological data. The steps of 
preprocessing include image analysis, background correction, normalization and data 
transformation
74
 
4.2.2. Background correction:  
The purpose of background correction is to eliminate background noise. The background noise is 
usually introduced by incomplete hybridization or washing steps. Background correction is 
adjusted by subtracting background intensity from foreground intensity
42
 for each probe. 
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4.2.3. Normalization 
In this process microarray spot intensities are adjusted in order to examine the variability across 
different experiments
74
. The goal of normalization is to remove systematic variation from the  
data. Systematic bias arises due to different labeling efficiencies scanning parameters
70
. 
Normalization results in consistent data
74
 so that each feature is comparable to all chips
75
. Data is 
normalized in such a way that data is independent of particular experiment and technology used.  
Normalization methods available in DetectiV are: 
1)Within array normalization: 
 Housekeeping genes, which have constant expression or external controls also known as 
negative control are require for normalization process
42
 Negative controls do not have any 
complementarity to the genes or genomes, and therefore can be used for normalization purposes.  
This type of normalization is generally used for adjusting signals of one single microarray. In 
this type of normalization each signal of array was divided by average intensities of all control 
probes per sample followed by log transformation.  
2) Between array normalization: 
 This type of normalization is utilized for comparing intensities between different samples of 
arrays. It is assumed that intensities or log ratios have similar distribution across a set of arrays, 
making them comparable. In this process the probe intensities of the amplified labeled samples 
are divided by the intensities of same probes intensities of the negative control array probes. This 
gives the log fold changes in expression level of probes with respect to a negative control. An 
obvious example for a negative control array may be RNA from a known uninfected animal or it 
contains water rather than sample. The negative control array therefore has a value for each 
specific probe representing that value we would expect to see if that specific probe has not 
hybridized to anything.    
3)  Normalization with median: 
  DetectiV offers an addition method that is the median method which calculates the global 
median value for each array. It is based on the assumption that most probes will not hybridize to 
anything.  If this assumption is false then this method should not be used. However, if the 
assumption holds, then the median is a good representation of that value which we would expect 
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to see from probes that have not hybridized to anything.  Since there was enough raw probe 
intensities detected both on control and amplified samples, this method could not give specific 
results and was thus discarded in this study.  All type of normalized data gives probes of high 
fold changes and are also tested for significance. Traditional statistical tests are used to test if any 
groups of probes or virus families in this case, are significantly different from zero. In all 
instances, after taking the log2, groups of probes that have not hybridized to anything should be 
normally distributed and have mean zero. 
4.2.4. Fold change, Log transformation and P values: 
Fold change is defined as the ratio of florescent intensity or it can be a difference of intensities in 
control and experiment
76,77
. This approach is applied to find the differentially expressed genes 
between control and experiment. An arbitrary threshold is selected and the fold change is 
considered if it is larger than threshold
42,74
. A cut off value of two fold up or down regulation is 
selected generally to distinguish differential expression and to produce reproducible results
42
.  
By applying specific mathematical functions data are transformed into different forms. The most 
common transformation in microarray studies is log2 of fold change or log ratio
76,77
 . 
 Importance of logarithmic transformation is to provide values that are interpretable, more 
meaningful from the biological point of view and also eliminate the misleading disproportion 
between two relative changes. It is often more convenient to use logarithms of the expression 
ratios than the ratios themselves because effects on intensity of microarray signals tend be 
multiplicative. The logarithm transformation converts these multiplicative effects (ratios) into 
additive effects (differences), which are easier to model 
76,78
.  
P-value is a measure of the evidence against the null hypothesis in a statistical test. It is the 
probability of the occurrence of a test statistic equal to, or more extreme than, the observed value 
under the assumption that the null hypothesis is true
76
.   
4.3. DetectiV software for analyzing Detectichip: 
DeteciV is a software package for exploratory data analysis, written in R language. Exploratory 
data analysis aid the process of analysis by hiding certain aspects of data and making visible 
important characters rather than analyzing whole spread sheet. It offers both graphical and non-
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graphical analysis and includes visualization tools for univariate (looking at one column at one 
time) and multivariate (looking at two or more than two column) data. 
The function of this software is to provide visualization, normalization and significant testing
13
 
The reason for using DetectiV software to analyze the detectichip in this study are that the 
software is basically collection of R functions and it thus open to all computer platforms like 
windows and Unix/Linux. This is independent of microarray technology used (e.g. Illumina or 
Affy chips) for instance. Its major advantage over E-predict is powerful visualization tools in 
form of bar plot
51
. 
4.3.1. Principle of DetectiV software: 
Like any other programming tools the first stage is to read the array data. This can be 
accomplished by the functions from limma, marray or other bioconductor packages specific for 
reading genepix files. Further advantages of DetectiV offers various inbuilt functions for further 
processing. Normalization may be carried out using the normalise() function, and data can be 
visualized using show.barplot() function. Finally, the do.t.test() function may be used to find 
significantly expressed pathogens group by families or names. It perform a t- test for each virus 
family and looks at the top ten ordered by p-value, filtered to have an average log2 scaled value 
>=1. Figure (12)shows the flowchart of the steps involved in data analysis. 
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Figure 12:  Principle of DetectiV software: This figure is adapted from
13
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4.4. Data analysis workflow in R 
R is a program for statistical computing which works in command driven language, typing 
commands). Bioconductor project is open source for developing open software
79
 dedicated to 
biological data analysis. Bioconductor core packages were installed in R. The most commonly 
known Bioconductor
79
 packages are limma, and marray.  
4.4.1. Packages 
Limma is a package for differential expression analysis of microarray data
80
. It can read many 
microarray scanner output formats and offer functions for their analysis. For one channel array, 
data can be represented as data matrix in which rows represents probes and column represents 
arrays or treatments 
80
.  
marray package is for analysis of two color arrays and provide functions for reading, 
normalization and graphical display 
81
 
Bioconductor packages need to be installed on R environment once and then can be loaded as 
libraries each time the scripts are run. The packages are installed by using biocLite() command 
on R which utilizes an R script present on Bioconductor website initially loaded by the command 
source().The libraries for installed packages are loaded by the library() command. 
 
source("http://www.bioconductor.org/biocLite.R") 
biocLite("limma") 
biocLite("marray") 
library(limma) 
library(marray) 
 
The functions provided by DetectiV were assembled in one file called “detectiv_all_packages.R” 
and read it in our program by the function source() such as: 
source("detectiv_all_packages.R") 
4.4.2. Reading Targets  
After installing libraries of required packages, the image analysis files (gpr files) produced from 
genepix pro software
7
are read in R. A target file is created with the names and properties of the 
raw data files and it is read in the variable ‘targets’ using the command readTargets().  
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targets <- readTargets("targets.txt") 
4.4.3. Preprocessing 
The gene pix result files(GPR) files have two columns for representing foreground and 
background probe intensities named F532 Mean and B532 Mean respectively.  These are read 
into a variable of class RG List using the read.maimages() function. RG list is a simple list for 
storing red and green channel foreground and background intensities for a batch of spotted array. 
The intensities represented by the red color are ignored since only one color was used in this 
assay. R, Rb, G, Gb represents column names for Red, Red background, Green and Green 
background intensities respectively. 
Cy3 <- "F532 Mean" 
b<-"B532 Mean" 
RG <- 
read.maimages(targets,source="genepix",columns=list(R=Cy3,G=Cy3,Rb=b,G
b=b)) 
RG$R <- NULL 
RG$Rb <- NULL 
Prepare.data() function is used to create a data files with the extracted expression values and 
combining them with the annotation values for the probes present on the chip. The probe 
annotation files consist of viral species names, probe sequences etc. 
 
grouping <-read.table(file= "Probe_annotation_full_control.txt",header 
= TRUE,sep="\t") 
gdata <- prepare.data(RG$G, RG$genes$ID, grouping, "ID") 
Further in this study known sample for adenovirus presence (sample 1) was assayed twice, thus 
an average of its probe intensities is calculated before further analysis and other samples are 
renamed accordingly. 
gdata<-cbind(gdata,0) 
gdata[,17]<-rowMeans(gdata[,4:5]) 
colnames(gdata)[17]<-'Sample 1 (Known)' 
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colnames(gdata)[2]<-'Sample 2 (Unknown)' 
colnames(gdata)[3]<-'Negative sample (control)' 
4.4.4. Visualization 
Graphs for visualization of various intensities are made with the help of show.barplot() function. 
Each black bar represents a unique probe ID, which is grouped together according to user-
defined annotation such as virus family names. The plots are saved in pdf format with the 
function pdf(). 
#making raw data plots 
pdf("plots/raw_data_plots/raw_control.pdf") 
show.barplot(gdata,"Name",3) 
dev.off() 
 
4.5. Visualizing raw probe intensities for each virus family 
Below the figure for three sample demonstrate the raw probe intensities 
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Figure 13: Raw probe intensities for each virus family in the three samples: Virus family names are 
shown on x axis and are also represented by background colors. The y axis represents raw probe 
intensities. Length of the peaks represents abundance of the corresponding virus family in the sample. 
Graph A represents Control sample, graph B represents Known or sample 1 and graph C represents 
Unknown or sample 2. Due to the high amount of positive signals. The data is not readable but shown 
here to represent because of certain reasons. These included that graphical representation appeared 
showed that software is working well and is favorable for further processes. The Peaks are not much 
visible because the data was not preprocessed yet.  More black color and less peaks are due to that lot 
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viral families are present in both sample. Sharp peaks were observed in control which indicates that viral 
families are present in negative control but in very less amount as it was expected.  
4.6. Background Correction of detectichip 
For background correction RG$G-RG$Gb is added as a parameter in the prepare.data() function 
and the mean for sample 1 is recalculated. Then we draw plots for background corrected 
samples. The plots are now drawn for only the probes with positive intensities and the probes 
with negative intensities were discarded. 
gdata <- prepare.data(RG$G-RG$Gb, RG$genes$ID, grouping, "ID")  
 
gdata<-cbind(gdata,0) 
gdata[,17]<-rowMeans(gdata[,4:5]) 
colnames(gdata)[17]<-'Sample 1 (Known)' 
colnames(gdata)[2]<-'Sample 2 (Unknown)' 
colnames(gdata)[3]<-'Negative sample (control)' 
 
pdf("plots/background_corrected_plots/bg_sample2.pdf") 
show.barplot(gdata[which(gdata[,2]>0),],"Name",2)  
dev.off() 
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Figure 14: Background corrected intensities averaged for each virus family in three samples: Virus 
family names are shown on x axis and are also represented by background colors. The y axis represents 
raw probe intensities. Length of the peaks represents abundance of the corresponding virus family in the 
sample. Graph A represents Control sample, graph B represents Known(Adenovirus) or sample 1 and 
graph C represents Unknown or sample 2. 
There is not much difference in raw data plots and background corrected plots. It is because here in this 
case data is not normalized yet. More black color and less peaks are due to that lot viral families are 
present in both sample. Sharp peaks were observed in control which indicate that viral families are 
present in negative control but in very less amount as it was expected.  
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4.7. Normalization and significance testing methods: 
4.7.1. With in array control method 
Normalization with negative controls presents on the arrays which ideally should have no 
intensities and thus their mean intensities are calculated to normalize other probes. The resulting 
data is again plotted for visualization. The results data is also written to an excel sheet to simplify 
results interpretation by using the command write.table(). 
controls <- grep("control", gdata$Name) 
ndata <- normalise(gdata, c(2:3,17), controls) 
pdf("plots/norm_with_controls/n_norm_sample2.pdf") 
show.barplot(ndata[which(ndata[,2]>0),],"Name",2) 
dev.off()
write.table(ndata,"ndata_control_on_array_3.xls",sep="\t",row.names=FA
LSE,quote=FALSE 
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Figure 15: Graphs for all the three samples normalized with average of the negative controls in 
samples. The data is grouped by virus families which are shown on x axis and are also represented by 
background colors. The y axis represents log2 FC of normalized probe intensities. Length of the peaks 
represents abundance of the corresponding virus family in the samples. Graph A represents Control 
sample, graph B represents Known ( adenovirus) or sample 1 and graph C represents Unknown or sample 
2. The three graphs indicated that in negative sample 7 families are showing increase log 2 fold change. In 
sample 2 and sample 1 peaks indicating many virus families are present there. 
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4.7.2. Normalization with Whole negative control array method 
Similarly the expression data is also normalized with the whole array as control sample to take 
into account the virus probes present in the known and unknown samples with comparison to the 
control array done with water. It is also visualized with plots and written to file for biological 
interpretation. 
#code for normalization with control array, plotting and writing data. 
 
adata <- normalise(gdata, c(2:5,17), carray=gdata[,3]) 
adata <- normalise(gdata, 2:5, carray=gdata[,3]) 
pdf("plots/norm_with_array/a_norm_sample2.pdf") 
show.barplot(adata[which(adata[,2]>0),],"Name",2,ylim=c(0,50)) 
dev.off() 
pdf("plots/norm_with_array/a_norm_control.pdf") 
show.barplot(adata[which(adata[,3]>=0),],"Name",3,ylim=c(0,50)) 
dev.off() 
pdf("plots/norm_with_array/a_norm_sample-avg.pdf") 
show.barplot(adata[which(adata[,17]>0),],"Name",17,ylim=c(0,50)) 
dev.off() 
 
write.table(adata,"adata_normalization_with_negative_sample_2.txt",sep
="\t",row.names=FALSE,quote=FALSE) 
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Figure 16: Graphs for all the three samples normalized with probe intensities in the controls 
sample. The data is grouped by virus families which are shown on x axis and are also represented by 
background colors. The y axis represents log2 FC of normalized probe intensities. Length of the peaks 
represents abundance of the corresponding virus family in the samples. Graph A represents Control 
sample, graph B represents Known or sample 1 and graph C represents Unknown or sample 2. 
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4.8. Significance testing 
Significance testing for each sample and for each of the virus families present in them is done by 
the function do.t.test(). This function provides a measure (P value) of  how significant are the 
intensities of virus families considering they are represented by multiple probes in one array and 
have variable intensities. Due to lack of probe annotation like virus species for all probes and the 
technical limitation for retrieving them, significant testing could not be done for any individual 
virus species. Thus it only indicates which virus families are significantly present in the control, 
known and unknown samples after they are normalized. The resulting files with Pvalues and 
average intensities are written to excel files. 
#sample code for t test calculation 
 
tt <- do.t.test(ndata, ndata$Name, 2) 
ignore <- ("control") 
tt <- tt[!tt$fv %in% ignore,] 
tt[tt$av>=1,][1:10,] 
write.table(tt,"results/sample2_significant_norm_control.xls",sep="\t"
,row.names=FALSE,quote=FALSE) 
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5-Results: 
5.1. Gel electrophoresis of PCR Product:  
The figure shows the PCR results of round B sample which are visualized on 1.5% agarose gel 
electrophoresis, sufficient to separate the fragments from 300-3000bp fragments. Round B 
sample was obtained taking cDNA (product of round A) as a template and than further 
amplifying with primer B. A smear was visualized around 200-1000bp indicated that primer is 
randomly bind to the target.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17: Gel electrophoresis after random PCR amplification of round B samples:  Indicated the 
appearance of bands in (known for adenovirus presence) sample 1 and unknown samples2. In known 
sample appearance of weaker band might be due to less concentrated sample, still showed that primer 
attached randomly to the nucleic acids. In known sample a smear of 200-1000bp indicated that primer 
attached randomly to the nucleic acid. In fourth well there is no appearance of band as there is no any 
sample. In first and last lane 1 Kb ladder is present.  
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5.2. Detection  of viral species within array control normalized data 
For deeper insights in the results, the probes with highest fold changes in the known and 
unknown samples were selected. Virus species of these probes were identified by aligning the 
sequences with nucleotide database with the BLAST tool. This resulted in some duplication of 
virus species as they are represented by multiple probes too.  This redundancy was removed by 
manually selecting the representative probes based on higher fold changes. Any negative fold 
change values of the selected probes in other samples were set to zero for better visualization and 
interpretation. 
 
The species detected as highly abundant in sample 1 and sample 2 after normalization through 
the negative controls present sample. Graph is drawn for comparing the species .  
Figure 18: PCR results by using T7 primers: No 
fragments are observed because T7 promer did not 
bind to nucleic acid 
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Figure 19: Virus species detection with the highest log2 FC values by with in array 
normalization method:  in unknown, known and control samples in the data normalized with 
controls within array. 
 
This table was made to show the higher Log2 fold change values and corresponding species in 
three samples. Yellow color indicates that those species were present in particular sample. Table 
2 shown below the graph. A comparison of their values is shown in figure 18 
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Species Negative sample Sample 1 (Known) Sample 2 (Unknown)
Opuntia virus X 0.00 0.00 10.84
Colorado tick fever virus 0.00 0.13 9.31
Avian hepatitis E virus 0.00 0.00 8.46
Hirame rhabdovirus 0.00 -3.18 8.36
Influenza A virus 0.00 10.90 8.11
Prochlorococcus phage 0.00 0.25 8.09
Hyposoter fugitivus ichnovirus 0.00 0.30 8.08
Wheat eqlid mosaic virus 0.00 0.22 8.08
Human DNA 0.00 0.29 8.08
Influenza B virus 0.00 -0.04 8.06
Euprosterna elaeasa virus 0.00 0.11 8.01
Glypta fumiferanae ichnovirus 0.60 0.23 7.70
Acidianus two-tailed virus 0.00 0.23 7.69
Mammalian orthoreovirus 0.00 7.69 7.69
Germiston virus 0.00 0.17 7.66
Foxtail mosaic virus 0.00 -0.38 7.52
Propionibacterium phage 0.00 0.19 7.51
Southern tomato virus 0.00 -0.75 7.19
Hantaan virus 0.00 9.01 3.46
Bluetongue virus 10 0.00 10.54 3.45
Human papillomavirus 0.00 7.82 3.37
Pyrobaculum spherical virus 0.00 9.27 3.37
Human coronavirus OC43 0.00 7.50 3.36
Penicillium chrysogenum virus 0.00 8.07 3.29
Snowshoe hare virus 0.00 7.45 3.22
Lymphocytic choriomeningitis virus 0.00 10.12 2.92
Little cherry virus 0.00 8.88 2.75
Puumala virus 0.00 7.43 2.25
Rice gall dwarf virus 3.31 1.16 0.85
Beet soil-borne mosaic virus 1.78 1.17 0.67
Anabaena variabilis 2.07 0.48 0.59
Spinach latent virus 0.57 0.33 0.14
Ralstonia phage RSM1 2.00 -1.99 -1.22
Human adenovirus C 1.09 10.54 -5.87
Micromonas pusilla reovirus 0.56 -6.41 -7.42
Table 2: Highly abundant virus species found after normalization through 
normalization with controls within arrays. The species detected as highly abundant in 
sample 1 and sample 2 after normalization through the negative controls present. They were 
made unique and the sample for which they were selected is highlighted in yellow. The table 
is sorted on the fold change values in sample 2 (unknown sample). 
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Thus the highly abundant species in sample 2 are  
 Opuntia virus X  
 Colorado tick fever virus 
 Avian hepatitis E virus 
 Hirame rhabdovirus 
 Influenza A virus 
 Prochlorococcus phage  
 Hyposoter fugitivus ichnovirus 
 Wheat eqlid mosaic virus 
 Human DNA  
 Influenza B virus 
Highly abundant species in known sample are  
 Influenza A virus 
 Human adenovirus C 
 Bluetongue virus 10 
 Lymphocytic choriomeningitis virus 
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5.2.1. Likely respiratory virus species in three samples by with in array control 
method: 
Likely respiratory virus species were detected from the with in array control method according to 
the high Log 2 fold change 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.2.2. Rare respiratory virus species detection by with in array control method 
The Detected viruses were further characterize as rare respiratory virus as there relevance with 
respiratory tract infection 
Species Negative sample Sample 1 (Known) Sample 2 (Unknown) Type Family
Influenza A virus 0.00 10.90 8.11 RNA orthomyxoviridae
Influenza B virus 0.00 0.00 8.06 RNA, orthomyxoviridae
Human coronavirus OC43 0.00 7.50 3.36 DNA Coronaviridae
Human adenovirus C 1.09 10.54 0.00 DNA Adenoviridae
Figure 20: Likely respiratory viruses in three samples after 
normalization with in array control method: The figure demonstrates 
Influenza A, B, Human corona  virus were detected species in sample 
2(unknown). Whereas in addition to theses viruses Human adenovirus C 
was detected in sample 1(known).  
 
Table 3: Indicted the detected viral species in three samples normalized with in array 
control method . In column of sample 1 and sample 2 ( unknown) the values of log2 fold 
change are shown 
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Species Negative sample Sample 1 (Known) Sample 2 (Unknown)
Mammalian orthoreovirus 0.00 7.69 7.69
Hantaan virus 0.00 9.01 3.46
Human papillomavirus 0.00 7.82 3.37
 
 
 
 
 
 
 
 
 
   Below the table show the Log 2 fold change values correspond to species.  
 
 
 
 
 
 
 
 
 
 
 
Figure 21: Detection of rare viral species in respiratory tract infection after 
normalization with in array control method: Mammalian orthoreovirus, Hantaan 
viruses and human papilloma viruses were detected in both samples.  
 
 
Table 4: Log 2 fold change values for  rare respiratory tract viruses (with in array 
control method) 
 
Characterizing viral diversity in Respiratory tract infection by DNA microarray technology 
   
 
Page 55 
 
  
 
5.3.  Viral species detection after normalized with  whole negative control 
array: 
 
 
Figure 22: Graph displaying the virus species with highest log2 fold changes from the data 
normalized with whole array as control. We see both known and unknown sample to have large 
number of different virus species.  
 Thus the highly abundant species found in unknown sample are 
 Wisteria vein mosaic virus 
 Yersinia phage Yep-phi 
 Machupo virus 
 Maize rayado fino virus 
 Latino virus 
 Human papillomavirus 
 Influenza A virus 
The highly abundant species found in the known sample are 
 Rotavirus A 
 Adenovirus type 12 
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Species Negative sample Sample 1 (Known) Sample 2 (Unknown)
Wisteria vein mosaic virus 0 18.60 18.73
Yersinia phage Yep-phi 0 18.71 18.73
Machupo virus 0 18.61 18.73
Maize rayado fino virus 0 18.70 18.73
Latino virus 0 18.70 18.73
Human papillomavirus 0 18.71 18.73
Influenza A virus 0 18.71 18.73
Ryegrass mosaic virus 0 18.59 18.72
Dendrolimus punctatus densovirus 0 18.46 18.72
Homo sapiens 0 18.71 18.72
Epizootic hemorrhagic disease virus 0 18.60 18.72
Pseudomonas phage 0 18.61 18.72
Lymantria dispar cypovirus 1 0 18.71 18.72
Glypta fumiferanae ichnovirus 0 18.71 18.71
Sweet potato chlorotic fleck virus 0 18.70 18.71
Rotavirus A 0 18.73 18.71
Enterobacteria phage VT2phi_272 0 18.72 18.70
Zucchini yellow mosaic virus 0 18.70 18.69
Streptomyces davawensis strain 0 18.72 18.68
Phlebovirus sp. Be An 356637 0 18.71 18.68
Karshi virus 0 18.72 18.64
Bluetongue virus 10 0 18.71 18.58
Parsnip yellow fleck virus 0 18.71 18.57
Staphylococcus phage 18 0 18.71 18.56
Hyposoter fugitivus ichnovirus 0 18.72 18.55
GB virus C 0 18.72 18.52
Adenovirus type 12 0 18.72 18.50
Human rhinovirus 0 18.70 18.49
Sphaeropsis sapinea RNA virus 1 0 18.71 18.46
Human adenovirus C 0 18.72 16.48
 Enterobacteria phage  
 GB virus C 
 Hyposoter fugitivus ichnovirus 
 Human adenovirus  
Below the table indicate the Log 2 fold change value of top species.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5 : Highly abundant virus species found after normalization through 
normalization with whole negative array  control. The species detected as highly 
abundant in sample 1 and sample 2 after normalization through the  whole  array (negative 
sample). They were made unique and the sample for which they were selected is 
highlighted in yellow. The table is sorted on the fold change values in sample 2 (unknown 
sample). 
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Species Negative sample Sample 1 (Known) Sample 2 (Unknown)
Influenza A virus 0 18.71 18.73
Adenovirus type 12 0 18.72 18.50
Human rhinovirus 0 18.70 18.49
Human adenovirus C 0 18.72 16.48
5.3.1. Likely virus species detection after whole negative control array 
normalization: 
The detected species were extracted from the above data due to their  likely relevance with 
disease 
 
 
 
 
 
 
 
 
The table is drawn to show the Log 2 fold change value for likely respiratory viruses  
 
 
 
 
 
 
 
5.3.2. Rare virus species detection after whole negative control array normalization 
The detected species were extracted from the above data due to their rare relevance with disease. 
The rare respiratory virus was detected in sample after whole arrays as negative control  method.  
 
Figure 23: Detection of likely respiratory tract viruses after whole 
negative control array normalization: This demonstrates the green and red 
bars indicated that Influenza A virus, Adeno virus 12, Human rhino virus is 
abundant in sample 1 and 2. In addition to these Human adeno virus C is 
present more in sample 1(known for adeno virus) as it was expected.  
 
Table 6: The values of Log 2 Fold change of likely viruses for each sample: 
Indicating that influenza A virus is present more in unknown sample 
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5.4. Significant Testing 
5.4.1. Significant testing for sample 1 n data 
 The n data was generated after normalization with in array control for each sample. The n data 
was further used for significant testing for sample 1. After significant testing different t value, p 
value statistical test generated results that are shown  table 8.   This significant testing was used 
to identify the increase expression for presence of significant viral family . Those viral families 
were selected which gave P value calculation less than 0.1, and also increase expression value.  
Table 8 : Significant virus families for samle 1 ndata:   P value <0.1, sorted on the average expression 
of probes representing  adenoviridae  family significantly present in known sample
 
3217331=(adenoviridae) 
Where  
0
5
10
15
20
Negative
sample
Sample 1
(Known)
Sample 2
(Unknown)
Rare viral specie in respiratory tract 
infection  
Human
papillomavirus
Species Negative sample Sample 1 (Known) Sample 2 (Unknown)
Human papillomavirus 0 18.71 18.73
fv nv tv pv av
Human_32 3 47150 0.07 12785
32127331 7 11720 0.03 0.82
Figure 24: Rare viral specie in respiratory tract 
infection: Normalization with whole negative control 
array methods indicated that Human papilloma virus is 
rare  respiratory tract virus 
Table 7: Log2 fold change values for each sample for rare respiratory 
virus: Indicating abundant human papilloma virus 
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fv=The name of the group, from grouping 
 tv=The value of the t statistic 
  pv=The p-value from the t-test 
  nv=The number of observations in the group 
  av=The mean value of the observations in column for each group 
5.4.2. Significant testing for sample 2 n data 
 The n data was further used for significant testing for sample 2. After significant testing 
different t value, p value statistical test generated results that are shown  table 9.   This significant 
testing was used to identify the increase expression for presence of significant viral family . 
Those viral families were selected which gave P value calculation less than 0.1, and also increase 
expression value. This test indicated that retroviridae family present significantly in sample 2 as 
shown in table 9.  
 
Table 9: Significant virus families with P value <0.1, sorted on the average expression of probes 
representing this family in unknown sample.  
 
8439395= Human endogenous retrovirus (Retroviridae) 
59976=Human endogenous retrovirus(Retroviridae) 
T-test on control indicated absence of any significant family as expected 
 
 
 
fv nv tv pv av
8439395 26 2.65 0.01 1.32
Human_32 3 2.26 0.08 1.05
59976 4 2.72 0.04 0.82
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fv nv tv pv av
Adenoviridae 664 15.13 0 10493.77
Bunyaviridae 2084 19.22 0 5578.24
Retroviridae 1988 20.66 0 4658.59
Papillomaviridae 1778 15.75 0 4618.71
Herpesviridae 1402 14.15 0 4558.59
Flaviviridae 1642 13.84 0 4321.58
Siphoviridae 2446 16.64 0 3397.58
Reoviridae 4546 20.2 0 3363.49
Flexiviridae 1598 14.77 0 3336.77
Orthomyxoviridae 7224 26.16 0 3312.67
5.4.3. Significant testing   for sample 1 a data :  
The a data was generated after whole negative array normalization method. The a data was 
further used for significant testing for sample 2. After significant testing different t value, p value 
statistical test generated results. Top  families are shown here in table 10.   This significant 
testing was used to identify the increase expression for presence of significant viral family . 
Those viral families were selected which gave P value calculation less than 0.1, and also increase 
expression value. This test indicate that adenoviridae present significantly in sample 1.  
 
 
 
 
 
 
 
 
 
5.4.4. Significant testing for  Sample 2 (unknown) a data:  
 A data was  generated after whole array as a normalization method. When significant testing 
were performed on sample 2 a data. The top 19 significantly virus families are shown in table 11.  
Table 11 : Following A data, table of top 19 significantly present virus families in the unknown 
sample for a data. The families are sorted on the average intensities of all the probes representing them 
in descending order. Some of the P values were very low and are rounded off to 0. There were 793 
families which were significant in sample 2, the most abundant being Tymoviridae.  
Table 10 : Following a data table of top 10 significantly present virus families in the known 
sample. The families were sorted on the average intensities of all the probes representing them in 
descending order. The P values were very low and are rounded off to 0. There were 271 families 
which were significant in sample 1, the most abundant being Adenoviridae. 
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6-Discussion 
In this report the demonstration of detecting viruses were reported. The goal was to detect 
respiratory viruses with DNA microarray technology.  For this purpose GPL13407 platform was 
utilized to fabricate the chip by Agilent technologies, as these probes were used in the previous 
studies
38,57
.  The probes were selected due to comprehensive nature of LLMDA platform.   
6.1. Gel electrophoresis of PCR product 
The second step was to amplify samples.  Two publication were found appropriate regarding 
amplification of samples which have used virochip assays
48,82
.  Random amplification process 
was done in this study rather than phi29 amplification because random primer amplification 
protocol was simple. Further more  other primers T7 primer were also checked for amplification 
but these primers were not able to bind the nucleic acid because many viruses lack poly A tail so, 
these primers require poly A tail to bind with. The results are shown in (figure 18 on page 49). 
 After amplifying with random primers the results were further evaluated with the gel 
electrophoresis. Interestingly smear of bands were detected indicated that primer randomly bind 
the target and amplified it. It is shown in (figure 17, page 48) proving usefulness of random 
primer for amplification.  But in sample 1 (known for adenovirus) the smear was light as 
compared to appearance of smear in the sample 2. There might be two possible reasons for this. 
Less titers of viral nucleic acid is present in sample 1(Known for Adenovirus) as compared to 
unknown sample 2. Moreover the dimer and hair pin formation is the consequences of intrapair 
secondary structure formation which can be formed between 17mer tag and a nonamer results, 
partial binding of the primer to its target in case of known sample 1(known for adenovirus). The 
appearance of light smear might be due to this reason.  
6.2. Preprocessing and visualization: 
The data was normalized with two method.  1) Normalization within array control method in 
which signal of array was divided by average intensities of all control probes per sample 
followed by log transformation. The data first visualized by making plots for three sample in 
detectiV software. Normalization with this method (figure 15-page 44) only shows that the 
known and unknown sample contain abundant viral families as indicated by there black color 
peaks). 
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The second normalization method was the 2) Normalization with whole negative control array 
was done by taking the average of one full negative control array intensities (control sample was 
used) on this array and the values were divided by each probe intensity for sample 1 and sample 
2. As the whole negative control array the average intensities were too much low. When they 
were divided by each probe intensities of other sample.  The result of log 2 fold change was 
again higher for sample 1 and sample 2 as shown in plots of (Figure 16 on page 46). The possible 
reason might be that whole one negative control array the water was used as negative sample. 
But if the sample from an healthy person will be used as negative sample than there might be a 
possibility that healthy person sample contain viruses more than presence of viruses in water. 
When the value for average intensity will be divided by the intensity values for the probes of 
infected person than less viral family will be appear that can visualized with plot. But as the 
negative sample on whole array control was water and it contain less viral families. So this 
results abundance viral families in other samples. 
6.3. Detection of virus species according Log2 fold change: 
 
 After normalization a those probe sequences were selected which gave the high log 2 fold 
change. As there was no information at the species level in annotation file. So the species with 
higher fold change were detected by aligning the sequences in BLAST. The sequences of those 
probes  were selected which gave high log 2 fold change. The  detected viral species were shown 
in (figure 19, page 50, by using with in array control normalization data)  and (figure 22 page 55 
whole negative control array) representing by green red peaks. These figures indicate the 
abundance species in samples. Many animal viruses, plant viruses , phages were also detected in 
the samples by those methods. Detection of phages on the array suggest a strategy of indirect 
detection of bacteria.  
Tables (table 2, page 51, and table 5, page 56) are also drawn below these figures so that one can 
easily compare the values for log 2 fold change  for corresponding species in three samples. 
6.4. Detection of Likely respiratory viruses  
As the samples were from nasal aspirates therefore those species were further characterized for  
likely respiratory viruses as the goal of this study was to characterize viral diversity. The likey 
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viruses figures are  shown (Figure 20, Page 53 and figure 23 on page 57). By comparing both 
methods of normalization it is indicated that sample 1(known for adenovirus) is abundant in 
adenovirus C species as it was expected.  In sample  2 (unknown) there was Influenza A virus 
because of its higher Log 2 fold change value. Here Log2 fold change is higher 8.11 (shown in 
table 3, page 57). These two viral species are more likely respiratory viruses as demonstrated in 
previous studies indicating that Influenza virus infects 5-15 % global population
83
. 
Finding suggests that influenza viruses are one the major causes of acute respiratory tract 
infection in pediatric sample. Influenza A virus was detected with both methods indicated that 
children (unknown sample 2) were more disposed to influenza A in this study. 
Second method of normalization with  whole  negative control array suggests that two types of 
adenoviruses were present in sample 1 (Figure 23 page 57) confirming that the  patient of sample 
1 is more disposed to adenovirus attack.  This finding suggests that the correct method was 
performed throughout, as this sample 1 was previously tested for Adenovirus presence. The 
results of DNA microarray indicates that adenovirus is present in sample 1.  
Human corona virus was detected as a likely virus in both samples by following, with in array 
control normalization method but not with whole negative array normalization method.  The 
presence of  human corona virus in both samples with in array control method suggests that this 
virus could be a causative agent
84
 .This  causes cold like illnesses and majorly cause upper 
respiratory tract infection in children and adult 
85,86
 .  
 
Human rhino virus was detected by using whole negative control array normalization method 
as shown in (figure 23, page 57). This  is a RNA virus, belong to family picornaviridae, and 
cause upper respiratory tract infection
87
. 
6.5. Detection of rare respiratory viruses: 
Data was further characterized for the presence of rare viruses associated with respiratory tract 
infection. Moreover the data for rare viral RTI suggests that the samples normalized with in array 
control method and with whole array as negative control method  indicated the detection of 
Human papilloma virus as shown in (figure 21, page 54 and figure 24 page 58). The results from 
both methods indicated that Human papilloma virus exists as rare virus in patients of 
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respiratory tract infection. Previous studies indicated that recurrent respiratory papillomatosis is a 
rare condition caused by human papilloma virus. These viruses cause respiratory distress and 
hoarsness. The papillomas of aerodigestive tract are observed in the patients
88
. Human 
papillomaviruses have been been detected previously in the respiratory tract and are commonly 
found in tumors in the lungs and the oropharynx
89,90
. 
 Mammalian orthoreovirus is also present as rare viral species with high log 2 fold change with 
in array control method (figure 21, page 54, and figure 24 page 58).  Previous studies suggests 
that Mammalian orthoreovirus is considered as a human respiratory disease agent able to infect 
man due to zoonotic bat borne transmission
91
. Reovirus stands for (Respiratory enteric orphan 
virus). They were first isolated in 1950 and were named as orphan virus because these viruses 
were not associated with any disease at that time.  These viruses have RNA genome and belong 
to reoviridae family
92
 and assume to be a rare virus in respiratory tract.  
Hanta virus with high fold change is  present in both samples as a rare viral RTI. Hantavirus 
causes hemorrhagic fever with renal syndrome. In 1933 a severe respiratory disease occurred in 
South Western USA. In those cases non cardiogenic pulmonary oedema was present. These 
infection were assumed due to hantavirus
93
. So it can be a possible explanation that these 
samples in this study   might have hantavirus as rare virus for respiratory tract. 
6.6. Significant testing  
Significant T tests  were performed on virus family level, due to lack of species level annotation. 
It gives an idea as to probes of which viral families are significantly expressed in the samples. 
Significance level (pv) of <0.1 was considered as a threshold for identification of virus families. 
Significant testing was performed after normalization within array control on sample 1 (known 
for presence of adenovirus), two hits were shown to be significant (table 8, page 58), one of 
which had very high average expression (av). This was represented by Human_32 indicating the 
presence of human genome in the sample as expected. The other significant hit showed that 
adenoviridae family is significantly present in sample 1(known for adenovirus).   
Unknown sample (table 9, page 59) significant testing performed on n data  showed that 3 hits 
were significant as there P-values were <0.1. This indicated that that Retroviridae ( human 
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endogenous retro virus) was significantly present which is likely as these retro virus are 
integrated in human and become a part of human genome . 
 By following significant tests on the negative control sample. The results suggested no viral 
family are significantly present in it. This was expected because control do not contain any 
sample but water.  
When significant testing was performed on a data (whole negative array control normalization) 
indicated many viral families which were significantly present.. For sample 1 (known for 
adenovirus presence)  the data indicated probes of  adenoviridae familiy to be significantly 
expressed and with highest expression values (table 10, page 60). The next viral family which 
was significantly present was the Bunyaviridae family. Hantaan virus also belongs to this family. 
Other family significantly present was retroviridae family. The Papillomaviridae family was also 
present significantly as the P value is zero. Reoviridae family and orthomyxoviridae (influenza 
virus belongs to this virus family) were among significant families.   
For unknow sample 2 the viral family significantly present were Tymovirididae and 
Herpesviridae ( shown in table 11 on page 60 ). These are plant virus families unlikely present in 
respiratory tract infection sample.  The othe viral family that was significantly expresed was 
podoviridae family. Bacteriophage is belong to this family.  Flexiviridae and retroviridae  are 
also expressed significantly.  
By comparing both methods it can be suggested that whole negative control array normalized 
data produced reliable results. As this method able to charatarize number of viruses in both 
species level and family level.  
6.7. Other pathogen detection:  
DNA microarray can also be utilized for nonviral pathogen detection. Interestingly in this study 
detectichip detected bacteriophages, like yersenia phage, pseudomonas phage, Enterobacteria 
phage, staphylococcus phage by whole negative array normalization method (were detected as 
shown in table 5 page 56). The phage is detected and possible explanation is that humans are 
constantly exposed to bacterial viruses. 
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6.8. Other aspects of detecti-chip:  
The majority of viruses detected with detecti chip are RNA viruses such as rhinoviruses and 
coronaviruses. Many previous studies have been  focused on the characterization of RNA viruses 
in the respiratory tract
94
 . But DNA virus was also detected on this detectichip.   
Major drawback of selecting fold change method is the arbitrary nature of cutoff value, lack of 
statistical measures and potential of biasing detract from its appeal 
95
. Other aspects like biases in 
random PCR amplification, cross hybridization effects, insufficiency of microarray data analysis 
poses difficulties in detection process .Although the cost of assay is high. Considering the cost 
on per test basis steps are taken to reduce chip cost so that point-of-care system would result in 
reduction of cost in near future. Future developments may leads to overcome the limitations of 
microarray technology such as designing more comprehensive coverage of respiratory pathogen, 
improving primer selection, merging chip device into portable device   gives benefit to point of 
care field.  More over there is need to develop more reliable statistical tools automated software 
so that one can easily interpret microarray data.  Microarray is highly sensitive as it can detect 
thousands of pathogens in less sample. This method is also highly specific as it can detect 
intended target. But sensitivity and specificity profile can be increase by carefully designing the 
experiment as each step tends to increase these profiles. Designing probes for specific target 
reduce cross hybridization and increase specificity. 
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7-Conclusion: 
In the clinical diagnostic and research DNA microarray technology serves as a genomic sensor to 
detect viruses in samples of respiratory tract infection. Due to broad panel of detection, high 
throughput technology seems most promising because microarry provides a sensitive  and 
specific way to detect multiple pathogen.  Despites its sensitive detection any challenges need to 
be addressed regarding start up cost, miniaturization, analysis tools. 
Investigations proposed that the selected statistical or fold change cut-off suggest that  
microarray analysis can offer essentially more than one answer, inferring data interpretation 
complex.  My findings detected that Influenza A virus is present more in unknown sample 2 with 
two normalized method indicating that children of unknown sample are more disposed to 
influenza attack.  Significant testing after whole array normalization confirms that adenoviridae 
family is significantly present in unknown sample. More over rare viruses were human papilloma 
virus which was detected with both methods in both sample. By comparing both methods the 
whole array normalization method was more accurate because this method provide accurate 
significant test for known sample for adenovirus.  
To my knowledge, this is the first demonstration of feasibility of using detectiV software 
implemented on LLMDA probes and amplified sample by following virochip protocol for 
identification of  respiratory tract viruses. The overall approach will facilitate rapid identification 
for broad spectrum of pathogens.  
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